This is an investigational study. Atezolizumab is FDA approved and commercially available for the treatment of non-small cell lung cancer and bladder cancer. Bevacizumab is FDA approved for the treatment of several types of cancer, but not thyroid cancer. It is investigational to give these drugs in combination to patients with thyroid cancer.